STOCK TITAN

Vertex Pharmaceuticals (NASDAQ: VRTX) insider Joy Liu reports share sales

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Vertex Pharmaceuticals insider sale notice: A Form 144 submission lists proposed or recent dispositions of Common stock by Joy Liu. The excerpt shows three reported sales in the past three months: 03/02/2026 (892 shares, $442,396.32), 04/01/2026 (978 shares, $439,288.26), and 05/01/2026 (1,104 shares, $469,222.08). The filing also records an allocation of 828 shares tied to Restricted Stock Vesting dated 02/26/2025.

Positive

  • None.

Negative

  • None.

Insights

Form 144 reports recent dispositions by an affiliate rather than an issuer action.

The excerpt lists three past sales by Joy Liu with exact share counts and dollar amounts for March, April, and May 2026. It also records Restricted Stock Vesting of 828 shares dated 02/26/2025.

These entries reflect routine Section 144 disclosures that notify the market of affiliate disposals; the filing does not state whether sales were open‑market, pursuant to a trading plan, or the cash‑flow recipient beyond the reported dollar amounts.

Restricted Stock Vesting 828 shares vesting date <date>02/26/2025</date>
Sale on 03/02/2026 892 shares <money>$442,396.32</money>
Sale on 04/01/2026 978 shares <money>$439,288.26</money>
Sale on 05/01/2026 1,104 shares <money>$469,222.08</money>
Form 144 regulatory
"144: Securities Sold During The Past 3 Months"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Restricted Stock Vesting financial
"Restricted Stock Vesting | Issuer | 828 | 02/26/2025"
Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.
Securities To Be Sold regulatory
"144: Securities To Be Sold Common | 02/26/2025"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did the Form 144 for VRTX report?

The Form 144 reports proposed or recent dispositions of Common stock by Joy Liu. It lists three sales: 892 shares on 03/02/2026 ($442,396.32), 978 shares on 04/01/2026 ($439,288.26), and 1,104 shares on 05/01/2026 ($469,222.08).

Were any shares from restricted stock vesting reported?

Yes; the filing lists 828 shares tied to Restricted Stock Vesting dated 02/26/2025. The line appears under "Securities To Be Sold" with the method labeled "Restricted Stock Vesting" and the recipient listed as the issuer.

Do the Form 144 entries state how the sales were executed?

No; the excerpt does not specify execution methods. The filing provides dates, share counts, and dollar amounts but does not state whether sales were open‑market, block trades, or pursuant to a trading plan.

Who is the reporting person named in the excerpt?

The excerpt identifies Joy Liu as the individual associated with the reported sales. The entries include Joy Liu's address and the three sale dates with corresponding shares and dollar values for March, April, and May 2026.